- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Europe
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Report
- April 2026
- 80 Pages
Denmark, Finland, ... Denmark, Finland, Iceland, Norway, Sweden
From €829EUR$959USD£700GBP
- Report
- April 2026
- 1443 Pages
Europe
From €948EUR$1,096USD£800GBP
- Report
- April 2026
- 537 Pages
United Kingdom
From €473EUR$547USD£399GBP
- Report
- December 2022
- 1560 Pages
Global
From €2238EUR$2,500USD£1,955GBP
- Report
- December 2022
- 50 Pages
Global
From €1790EUR$2,000USD£1,564GBP
- Report
- December 2022
- 54 Pages
Global
From €1790EUR$2,000USD£1,564GBP
- Report
- December 2022
- 37 Pages
Global
From €1790EUR$2,000USD£1,564GBP
- Report
- December 2022
- 54 Pages
Global
From €1790EUR$2,000USD£1,564GBP
- Report
- December 2022
- 35 Pages
Global
From €1790EUR$2,000USD£1,564GBP
- Report
- December 2022
- 59 Pages
Global
From €1790EUR$2,000USD£1,564GBP
- Report
- December 2022
- 322 Pages
Global
From €2238EUR$2,500USD£1,955GBP
- Report
- December 2022
- 2271 Pages
Global
From €2238EUR$2,500USD£1,955GBP

The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs.
The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more